Page 64 - Pharma

Natco's US partner Breckenridge files ANDA for everolimus

Novartis sells everolimus tablets under the Zortress brand, which has generated sales of $ 43.5 million for the 12-month period ending July 2014

Indian pharma companies need to tap unexplored markets to boost revenues

As part of risk mitigation strategies, Indian companies should expore untapped markets such as South America, GCC, CIS, Japan, etc in addition to the US and Europe

Cipla launches generic version of Advair asthma drug in Germany, Sweden

Advair is GSK's $8 billion-a-year brand. Cipla's new launch is expected to give a major boost to its performance in the Europe

Govt plans 100% FDI for medical devices manufacturing

The centre government is reportedly considering a proposal to have a separate policy for medical devices industry

Wockhardt's 2 drugs receive USFDA's QIDP status

QIDP status allows for fast track review of the drug application by USFDA paving way for an early launch fast-tracks approval for Wockhardt drugs

Albemarle completes sale of ibuprofen and other businesses to SI Group

In April this year, Albemarle had entered into a pact to sell antioxidant, ibuprofen and propofol businesses to SI Group

Piramal Enterprises-Navin Fluorine JV plans to invest Rs 120 crore

Two companies have formed a joint venture to develop specialty fluorochemicals for applications in healthcare industry

Israel's Teva inks pact with Venus Remedies for cancer drug

Teva will use Venus infrastructure and regulatory competence for commercialisation of this blockbuster drug in Canadian market

NPPA grants price exemption for Torrent Pharma's FDC drug

This is the first product under the new drug pricing policy to receive exemption

Six AIIMS-like hospitals to be set up in UP

The centre plans to modernise six government medical college hospitals into super-speciality institutions

Roche's $8.3 bn deal to buy InterMune to strengthen respiratory portfolio

InterMune's lead product pirfenidone for idiopathic pulmonary fibrosis to expand Roche's respiratory product portfolio

PPP model for water industry is not viable: Rajesh Sharma

In this interview, Rajesh Sharma, CMD, Ion Exchange India, feels that water tariff needs to be raised for the PPP model to become successful

Indian educational institutions need serious introspection: Pranab Mukherjee

Central universities asked to create innovative hubs for search of local innovators, identification of their products and marketing of the same

Centre to raise research fund for promoting innovation

According to Dr Jitendra Singh, the centre will encourage PPP in view of the emerging areas of innovation

USFDA warns Marck Biosciences for GMP violation

The US drug regulator has issued an import alert for the company's products manufactured at its Kheda unit into the US

Ranbaxy may have to pay Rs 242 crore fine in US

The latest penalty has been imposed due to violations found at its API manufacturing factory in Toansa, Punjab

Dr Reddy's denies packaging violation allegation in US

US justice department is reportedly probing Dr Reddy's for breaching packaging norms

Claris Lifesciences plans to expand capacity at new plant

The company recently received approval from UK's MHRA for its new facility (ie, Plant 2), which will help it tap the regulated markets, especially the European region

USFDA gives nod for Zydus Cadila's acyclovir tablets

Anti-viral drug acyclovir tablets recorded sales of $55.8 in 2014 in the US, says IMS

Thermo Fisher Scientific sells Cole-Parmer to GTCR for $480 mn

Cole-Parmer is a provider of fluid handling, test and measurement, and electrochemistry products and services